Results 71 to 80 of about 7,978 (176)

Boron‐10 carriers and their applications in boron neutron capture therapy

open access: yesPrecision Radiation Oncology, EarlyView.
Summary of different types of boron drugs. Abstract Boron neutron capture therapy (BNCT) has emerged as a promising therapeutic modality in cancer treatment, demonstrating the ability to selectively eliminate cancer cells through the 10B(n,α)7Li nuclear reaction with minimal side effects on normal tissues.
Dachao Tang   +7 more
wiley   +1 more source

Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity [PDF]

open access: yes, 2014
YesWe report the encapsulation of highly hydrophobic 16-electron organometallic ruthenium and osmium carborane complexes [Ru/Os(p-cymene)(1,2-dicarba-closo-dodecarborane-1,2-dithiolate)] (1 and 2) in Pluronic® triblock copolymer P123 core–shell micelles.
Aird   +99 more
core   +3 more sources

Novel Isoniazid-Carborane Hybrids Active In Vitro against Mycobacterium tuberculosis

open access: yesPharmaceuticals, 2020
Tuberculosis (TB) is a severe infectious disease with high mortality and morbidity. The emergence of drug-resistant TB has increased the challenge to eliminate this disease.
Daria Różycka   +9 more
doaj   +1 more source

The synthesis and unexpected solution chemistry of thermochromic carborane-containing osmium half-sandwich complexes [PDF]

open access: yes, 2015
YesThe functionalisation of the 16-electron complex [Os(η6-p-cymene)(1,2-dicarba-closo-dodecarborane- 1,2-dithiolato)] (1) with a series of Lewis bases to give the 18-electron complexes of general formula [Os(η6-p-cymene)(1,2-dicarba-closo ...
Alison Rodger   +34 more
core   +2 more sources

(1,2-Dicarba-closo-dodecaboranyl)trimethylmethanaminium iodide

open access: yesActa Crystallographica Section E, 2011
The title compound, [1-(CH3)3NCH2-1,2-C2B10H11]+·I− or C6H22B10N+·I−, was obtained by the reaction of (1,2-dicarba-closo-dodecaboranyl)dimethylmethanamine with methyl iodide.
Jong-Dae Lee   +3 more
doaj   +1 more source

$\alpha$- and $\beta$- Relaxation Dynamics of a fragile plastic crystal

open access: yes, 2006
We present a thorough dielectric investigation of the relaxation dynamics of plastic crystalline Freon112, which exhibits freezing of the orientational degrees of freedom into a glassy crystal below 90 K. Among other plastic crystals, Freon112 stands out
Loidl, A.   +2 more
core   +1 more source

Competition between Halogen, Hydrogen and Dihydrogen Bonding in Brominated Carboranes [PDF]

open access: yes, 2016
Halogen bonds are a subset of noncovalent interactions with rapidly expanding applications in materials and medicinal chemistry. While halogen bonding is well known in organic compounds, it is new in the field of boron cluster chemistry.
Allen   +31 more
core   +2 more sources

Synthesis of Novel Planar-Chiral Charge-Compensated nido-Carborane-Based Amino Acid

open access: yesMolecules
Amino acids with unusual types of chirality and their derivatives have recently attracted attention as precursors in the synthesis of chiral catalysts and peptide analogues with unique properties.
Dmitry A. Gruzdev   +5 more
doaj   +1 more source

Modeling Changes in Measured Conductance of Thin Boron Carbide Semiconducting Films Under Irradiation [PDF]

open access: yes, 2016
Semiconducting, p-type, amorphous partially dehydrogenated boron carbide films (a-B10C2+x:Hy) were deposited utilizing plasma enhanced chemical vapor deposition (PECVD) onto n-type silicon thus creating a heterojunction diode.
Ianno, Natale J.   +3 more
core   +2 more sources

Boron Neutron Capture Therapy at a Crossroads: Translational Gap and Emerging Delivery Agents

open access: yesChemistry – A European Journal, Volume 32, Issue 17, 5 May 2026.
This review surveys recent advances in boron delivery agents for BNCT, emphasizing the shift from classical small molecules to multifunctional nanocarriers and theranostic systems. By integrating targeting, imaging, and therapy, next‐generation boron compounds aim to bridge the gap between (bio)chemical innovation and clinical translation.
Christoph Selg, Evamarie Hey‐Hawkins
wiley   +1 more source

Home - About - Disclaimer - Privacy